Emerging and High Growth Companies

Morphocell Technologies Inc. in its completion of US$50-million Series A Morphocell Technologies Inc. in its completion of US$50-million Series A

Morphocell Technologies Inc.

Home About Us Representative Work

Expertise
Emerging and High Growth Companies Technology
Key Contact
Nathalie Beauregard

Partner, Emerging and High Growth Companies, Montréal

Team
Chris Yangchen Wu

Associate, Emerging and High Growth Companies, Montréal

Marissa Kyres

Associate, Corporate, Montréal

On December 2, 2025, Morphocell Technologies Inc. announced it completed US$50-million Series A financing following a US$10-million add-on led by Investissement Québec.

Morphocell Technologies Inc., is a biotechnology company.

Osler, Hoskin & Harcourt LLP advised Morphocell Technologies Inc. with a team consisting of Nathalie Beauregard, Chris Yangchen Wu, and Marissa Kyres (Emerging and High Technology Companies).

Value
US$50 million
Date Announced
December 2, 2025
Lead Office
Montreal
Key Contact
Nathalie Beauregard

Partner, Emerging and High Growth Companies, Montréal

Team
Chris Yangchen Wu

Associate, Emerging and High Growth Companies, Montréal

Marissa Kyres

Associate, Corporate, Montréal

RELATED EXPERTISE

Find out how we can help you achieve extraordinary results

We have an undisputed reputation for solving problems, removing obstacles, and providing the answers you need, when you need them.

Work with us

Osler is a leading business law firm practising internationally from offices across Canada and in New York. Our clients include industry and business leaders in all segments of the market and at various stages in the growth of their businesses. We have built our reputation on our commitment to our clients' success and the experience, expertise and collaborative approach for which we are recognized. We believe that our success is a reflection of our clients' success.